Abstract
Purpose
Multidisciplinary teams have become increasingly desirable for managing complex disease but little objective data exist to support this approach. The aim of our study was to determine the impact of a multidisciplinary clinic on the management of colorectal cancer.
Methods
Data were prospectively collected on all patients with newly diagnosed colorectal cancer referred to the multidisciplinary clinic at our institution in 2009 and compared to a control group of all patients managed outside the clinic from 2008 to 2009. Comprehensiveness of preoperative evaluation was determined by frequency of abdominal and chest CT, CEA testing, and transrectal ultrasound. Access to multimodal care was measured by frequency of oncology consultation and treatment, advanced pathology testing, genetics counseling, and trial enrollment.
Results
Two hundred eighty-eight patients met inclusion criteria; 88 patients were referred to the clinic (40 preoperative, 48 postoperative) and 200 patients were managed outside. Complete preoperative evaluation was accomplished three times more frequently in clinic patients (85 vs. 23 %, p < 0.0001) with significant improvements in all parameters. Enhanced access to multimodal therapy was demonstrated in clinic patients by increased frequency of oncology consultation (98.9 vs. 61.5 %, p < 0.0001) and treatment (62.5 vs. 41.5 %, p = 0.02), advanced pathology testing (29.6 vs. 10.6 %, p = 0.0001), and genetics counseling (6.8 vs. 1.6 %, p = 0.28). Clinic patients also received significantly higher rates of neoadjuvant therapy for stage II or greater rectal cancer (82.6 vs. 30.9 %, p = 0.0001).
Conclusions
Multidisciplinary clinic management of colorectal cancer is associated with a significantly more complete preoperative evaluation as well as improved access to multimodal therapy.
Similar content being viewed by others
References
American Cancer Society Website. Available at http://www.cancer.org/cancer/ colonandrectumcancer/detailedguide/colorectal-cancer-key-statistics. Accessed 19 Nov 2010
Mitry E, Fields ALA, Bleiberg H et al (2008) Adjuvant chemotherapy after potentially curative resection of metastases from colorectal cancer: a pooled analysis of two randomized trials. J Clin Oncol 26:4906–4911
Sargent DJ, Goldberg RM, Jacobson SD et al (2001) A pooled analysis of adjuvant chemotherapy for resected colon cancer in elderly patients. N Engl J Med 345:1091–1097
Sargent D, Sobrero A, Grothey A et al (2009) Evidence for cure by adjuvant therapy in colon cancer: observations based on individual patient data from 20,898 patients on 18 randomized trials. J Clin Oncol 27:872–877
Wong RKS, Tandan V, De Silva S, Figueredo A (2007) Pre-operative radiotherapy and curative surgery for the management of localized rectal carcinoma. Cochrane Database Syst Rev 2:CD002102
Fleissig A, Jenkins V, Catt S, Fallowfield L (2006) Multidisciplinary teams in cancer care: are they effective in the UK? Lancet Oncol 7:935–943
Valicenti RK, Gomella LG, El-Gabry EA et al (2000) The multidisciplinary clinic approach to prostate cancer counseling and treatment. Semin Urol Oncol 18:188–191
Garcia-Granero E, Marti-Obiol R, Gomez-Barbadillo J et al (2001) Impact of surgeon organization and specialization in rectal cancer outcome. Colorectal Dis 3:179–194
Khani MH, Smedh K (2010) Centralization of rectal cancer surgery improves long-term survival. Colorectal Dis 12:874–879
Morris E, Haward RA, Gilthorpe MS, Craigs C, Forman D (2008) The impact of the Calman–Hine report on the processes and outcomes of care for Yorkshire’s breast cancer patients. Ann Oncol 19:284–291
Morris E, Haward RA, Gilthorpe MS, Craigs C, Forman D (2006) The impact of the Calman–Hine report on the processes and outcomes of care for Yorkshire’s colorectal cancer patients. Br J Cancer 95:979–985
Smedh K, Olsson L, Johansson H, Aberg C, Andersson M (2001) Reduction of postoperative morbidity and mortality in patients with rectal cancer following the introduction of a colorectal unit. Br J Surg 88:273–277
Wilks JA, Liebig C, Tasleem SH et al (2009) Rectal cancer patients benefit from implementation of a dedicated colorectal cancer center in a Veterans affairs medical center. Am J Surg 198:100–104
Dahlberg M, Glimelius B, Pahlman L (1999) Changing strategy for rectal cancer is associated with improved outcome. Br J Surg 86:379–384
Dillman RO, Chico SD (2005) Cancer patient survival improvement is correlated with the opening of a community cancer center: comparisons with intramural and extramural benchmarks. J Oncol Pract 1:84–92
Bokey EL, Chapuis PH, Dent OF, Newland RC, Koorey SG, Zelas PJ, Stewart PJ (1997) Factors affecting survival after excision of the rectum for cancer: a multivariate analysis. Dis Colon Rectum 40:3–10
Aitken RJ (1996) Mesorectal excision for rectal cancer. Br J Surg 83:214–216
Enker WE, Thaler HT, Cranor ML, Polyak T (1995) Total mesorectal excision in the operative treatment of carcinoma of the rectum. J Am Coll Surg 181:335–346
Holm T, Johansson H, Cedermark B, Ekelund G, Rutqvist LE (1997) Influence of hospital- and surgeon-related factors on outcome after treatment of rectal cancer with or without preoperative radiotherapy. Br J Surg 84:657–663
Porter GA, Soskolne CL, Yakimets WW, Newman SC (1998) Surgeon-related factors and outcome in rectal cancer. Ann Surg 227:157–167
Read TE, Myerson RJ, Fleshman JW et al (2002) Surgeon specialty is associated with outcome in rectal cancer treatment. Dis Colon Rectum 45:904–914
Menon S, Valentini RP, Kapur G, Layfield S, Mattoo TK (2009) Effectiveness of a multidisciplinary clinic in managing children with chronic kidney disease. Clin J Am Soc Nephrol 4:1170–1175
Branagan G, Davies N (2004) Early impact of centralization of oesophageal cancer surgery services. Br J Surg 91:1630–1632
Newman EA, Guest AB, Helvie MA et al (2006) Changes in surgical management resulting from case review at a breast cancer multidisciplinary tumor board. Cancer 107:2346–2351
Stephens MR, Lewis WG, Brewster AE et al (2006) Multidisciplinary team management is associated with improved outcomes after surgery for esophageal cancer. Dis Esophagus 19:164–171
Granger SR, Glasgow RE, Battaglia J et al (2005) Development of a dedicated hepatopancreaticobiliary program in a university hospital system. J Gastrointest Surg 9:891–895
Forrest LM, McMillan DC, McArdle CS, Dunlop DJ (2005) An evaluation of the impact of a multidisciplinary team, in a single centre, on treatment and survival in patients with inoperable non-small-cell lung cancer. Br J Cancer 93:977–978
Junor EJ, Hole DJ, Gillis CR (1994) Management of ovarian cancer: referral to a multidisciplinary team matters. Br J Cancer 70:363–370
Vasen HF, Moslein G, Alonso A et al (2010) Recommendations to improve identification of hereditary and familial colorectal cancer in Europe. Fam Cancer 9:109–115
Rodriguez-Moranta F, Castells A, Andreu M et al (2006) Clinical performance of original and revised Bethesda guidelines for the identification of MSH2/MLH1 gene carriers in patients with newly diagnosed colorectal cancer: proposal of a new and simpler set of recommendations. Am J Gastroenterol 101:1104–1111
Julie C, Tresallet C, Brouquet A et al (2008) Identification in daily practice of patients with Lynch syndrome (hereditary nonpolyposis colorectal cancer): revised Bethesda guidelines-based approach versus molecular screening. Am J Gastroenterol 103:2825–2835
Southey MC, Jenkins MA, Mead L et al (2005) Use of molecular tumor characteristics to prioritize mismatch repair gene testing in early-onset colorectal cancer. J Clin Oncol 23:6524–6532
Terdiman JP, Gum JR Jr, Conrad PG et al (2001) Efficient detection of hereditary nonpolyposis colorectal cancer gene carriers by screening for tumor microsatellite instability before germline genetic testing. Gastroenterology 120:21–30
Trano G, Sjursen W, Wasmuth HH, Hofsli E, Vatten LJ (2010) Performance of clinical guidelines compared with molecular tumour screening methods in identifying possible Lynch syndrome among colorectal cancer patients: a Norwegian population-based study. Br J Cancer 102:482–488
Sauer R, Becker H, Hohenberger W et al (2004) Preoperative versus postoperative chemoradiotherapy for rectal cancer. N Engl J Med 351:1731
Roh MS, Colangelo LH, O’Connell MJ et al (2009) Preoperative multimodality therapy improves disease-free survival in patients with carcinoma of the rectum: NSABP R-03. J Clin Oncol 27:5124–5130
Acknowledgments
The authors thank Thomas Riggs, MD; Dana Zakalik, MD and Lyndsay Dohany, CGC (Beaumont Cancer Genetics Program); and Joyce Tull, RN, BSN (Beaumont Cancer Clinical Trials Office) for their contributions to this study.
Author information
Authors and Affiliations
Corresponding author
Additional information
This paper was submitted as poster presentation at the meeting of The American Society of Colon and Rectal Surgeons, Minneapolis, MN, May 15 to 19, 2010.
Rights and permissions
About this article
Cite this article
Levine, R.A., Chawla, B., Bergeron, S. et al. Multidisciplinary management of colorectal cancer enhances access to multimodal therapy and compliance with National Comprehensive Cancer Network (NCCN) guidelines. Int J Colorectal Dis 27, 1531–1538 (2012). https://doi.org/10.1007/s00384-012-1501-z
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s00384-012-1501-z